Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: A prospective study by AIDS Clinical Trials Group 5170.
Author Department
Medicine
Document Type
Article, Peer-reviewed
Publication Date
5-1-2007
Abstract
BACKGROUND: We sought to determine the safety of treatment interruption (TI) and to identify parameters that would define patients with human immunodeficiency virus (HIV) for whom TI is safer. METHODS: AIDS Clinical Trials Group 5170 was a multicenter, 96
Publication ISSN
1097-0339
Recommended Citation
J Infect Dis. 2007 May 15;195(10):1426-36. Epub 2007 Apr 6.
COinS